P/E Ratio
Updated 201h ago
Sector Performance
70th percentileEXR
32.8x
Sector Median
24.7x
Sector Avg
36.0x
Deep Analysis
A P/E ratio of 32.8x means that for every $1 of earnings the company generates, investors are currently paying $32.80 for the stock — a high multiple that typically indicates the market expects strong future earnings growth.
Among sector peers, where the median P/E is 24.1x, EXR sits at the 70th percentile, meaning 70% of peers have a lower P/E and the stock is priced above the typical peer valuation. The year-over-year change is not available, but quarter-over-quarter the P/E has risen by 5.4%, moving from 31.1x to the current 32.8x. This combination of a P/E well above the sector median alongside a rising quarterly trend points to an elevated valuation that could increase investment risk if earnings fail to meet growth expectations. At the same time, the higher multiple may reflect anticipated outperformance, creating a balanced risk-opportunity profile. This metric supports the overall NEUTRAL verdict: the premium valuation is notable, but without a longer trend or a clear catalyst, it does not alone justify a bullish or bearish stance.
Frequently Asked Questions
What does the P/E Ratio tell investors about EXR?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
Who are EXR's closest peers by P/E Ratio?
The closest peers by P/E Ratio include: VICI (9.1x), OMF (9.0x), JACK (8.5x), GIS (8.4x), FIS (8.4x).
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master EXR's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full EXR research report →EXR
32.8x
Sector Median
24.7x
Sector Avg
36.0x
How EXR's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.